Samjin Pharmaceuticals Co., Ltd. (005500.KS)

KRW 18280.0

(-0.33%)

Long Term Debt Summary of Samjin Pharmaceuticals Co., Ltd.

  • Samjin Pharmaceuticals Co., Ltd.'s latest annual long term debt in 2023 was 4.16 Billion KRW , down -90.24% from previous year.
  • Samjin Pharmaceuticals Co., Ltd.'s latest quarterly long term debt in 2024 Q1 was 2.08 Billion KRW , down -50.0% from previous quarter.
  • Samjin Pharmaceuticals Co., Ltd. reported annual long term debt of 42.67 Billion KRW in 2022, up 6.71% from previous year.
  • Samjin Pharmaceuticals Co., Ltd. reported annual long term debt of 39.98 Billion KRW in 2021, up 454.23% from previous year.
  • Samjin Pharmaceuticals Co., Ltd. reported quarterly long term debt of - KRW for 2024 Q2, down -100.0% from previous quarter.
  • Samjin Pharmaceuticals Co., Ltd. reported quarterly long term debt of 4.16 Billion KRW for 2023 Q4, down -33.33% from previous quarter.

Annual Long Term Debt Chart of Samjin Pharmaceuticals Co., Ltd. (2023 - 2007)

Historical Annual Long Term Debt of Samjin Pharmaceuticals Co., Ltd. (2023 - 2007)

Year Long Term Debt Long Term Debt Growth
2023 4.16 Billion KRW -90.24%
2022 42.67 Billion KRW 6.71%
2021 39.98 Billion KRW 454.23%
2020 7.21 Billion KRW 924.56%
2019 704.2 Million KRW 0.0%
2018 - KRW 0.0%
2017 - KRW 0.0%
2016 - KRW 0.0%
2015 - KRW 0.0%
2014 - KRW 0.0%
2013 - KRW 0.0%
2012 - KRW 0.0%
2011 - KRW -100.0%
2010 3 Billion KRW 0.0%
2009 - KRW -100.0%
2008 9 Billion KRW 50.0%
2007 6 Billion KRW 0.0%

Peer Long Term Debt Comparison of Samjin Pharmaceuticals Co., Ltd.

Name Long Term Debt Long Term Debt Difference
Yuyu Pharma, Inc. 13.64 Billion KRW 69.453%
Dong-A Socio Holdings Co., Ltd. 202.06 Billion KRW 97.938%
Ildong Holdings Co., Ltd. 29.87 Billion KRW 86.054%
HANDOK Inc. 123.78 Billion KRW 96.634%
Kukje Pharma Co., Ltd. 475.74 Million KRW -775.818%
Yuhan Corporation 60.23 Billion KRW 93.083%
Dong-A ST Co., Ltd. 161.99 Billion KRW 97.428%
SAMSUNG PHARM. Co., LTD. 101.81 Million KRW -3992.251%
Hanmi Pharm. Co., Ltd. 82.02 Billion KRW 94.92%
Hanall Biopharma Co.,Ltd 590.3 Million KRW -605.84%
Ilyang Pharmaceutical Co.,Ltd 6.05 Billion KRW 31.13%
Dong Sung Bio Pharm.Co.,Ltd. 18.52 Billion KRW 77.505%
MYUNGMOON Pharm co.,Ltd 12.58 Billion KRW 66.89%
Hana Pharm Co., Ltd. 1.59 Billion KRW -160.603%
Yuyu Pharma, Inc. 13.64 Billion KRW 69.453%
Ilsung Pharmaceuticals Co., Ltd. 119.67 Million KRW -3381.531%
REYON Pharmaceutical Co., Ltd. 121 Billion KRW 96.556%
Aprogen pharmaceuticals,Inc. 32 Billion KRW 86.979%
JW Holdings Corporation 20.65 Billion KRW 79.83%
Ildong Pharmaceutical Co., Ltd. 14.82 Billion KRW 71.895%
Chong Kun Dang Pharmaceutical Corp. 30 Billion KRW 86.111%
JW Pharmaceutical Corporation 30 Billion KRW 86.111%
Shin Poong Pharm.Co.,Ltd. 218.96 Million KRW -1802.914%
Hyundai Pharmaceutical Co., Ltd. 580.64 Million KRW -617.587%
Samil Pharmaceutical Co.,Ltd 49.56 Billion KRW 91.594%
Jeil Pharmaceutical Co.,Ltd 4.45 Billion KRW 6.41%
Yuyu Pharma, Inc. 13.64 Billion KRW 69.453%
Kwang Dong Pharmaceutical Co., Ltd. 19.02 Billion KRW 78.102%
Daewoong pharmaceutical Co.,Ltd 93.41 Billion KRW 95.54%
JW Pharmaceutical Corporation 30 Billion KRW 86.111%
Yuhan Corporation 60.23 Billion KRW 93.083%
Jeil Pharma Holdings Inc 10.5 Billion KRW 60.318%
Yungjin Pharm. Co., Ltd. 40.37 Billion KRW 89.681%
Suheung Co., Ltd. 74 Billion KRW 94.37%
JW Pharmaceutical Corporation 30 Billion KRW 86.111%
Korea United Pharm Inc. 10.96 Billion KRW 61.992%
CKD Bio Corp. 69.43 Billion KRW 93.999%
Daewon Pharmaceutical Co., Ltd. 34.57 Billion KRW 87.949%
Dongwha Pharm.Co.,Ltd 16.12 Billion KRW 74.165%
Whan In Pharm Co.,Ltd. 307.05 Million KRW -1256.963%
Shin Poong Pharm.Co.,Ltd. 218.96 Million KRW -1802.914%
Chong Kun Dang Holdings Corp. 72.11 Billion KRW 94.222%
Boryung Corporation 151.7 Billion KRW 97.254%
Bukwang Pharmaceutical Co., Ltd. 78.52 Billion KRW 94.694%
Ilyang Pharmaceutical Co.,Ltd 6.05 Billion KRW 31.13%
JW Lifescience Corporation 168 Million KRW -2380.143%